<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-37156" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dakin Solution</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Keyes</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Grand Strand Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jamal</surname>
            <given-names>Zohaib</given-names>
          </name>
          <aff>Rawalpindi Medical University, Rawalpindi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thibodeau</surname>
            <given-names>Rachel</given-names>
          </name>
          <aff>Wyckoff Heights Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Keyes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zohaib Jamal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachel Thibodeau declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-37156.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Dakin solution, also called Dakin fluid or Carrel-Dakin fluid, is a dilute sodium hypochlorite (NaClO) solution commonly known as bleach. The sodium peroxide (NaO) and hydrochloric acid (HCl) mixture produces sodium hypochlorite. The main active agent in Dakin solution is created when the chlorine reacts with water in the environment to form hypochlorous acid (HClO). This hypochlorous acid produces a potent antibacterial effect in tissues. This activity reviews the mechanism of action, adverse event profile, toxicity, and administration of Dakin solution as it applies to the clinical setting.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for the use of Dakin solution in a clinical setting.</p></list-item><list-item><p>Explain the potential adverse effects of Dakin solution.</p></list-item><list-item><p>Describe the various strengths of Dakin solution and which is best in the clinical setting.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance patient care delivery when using Dakin solution for its intended indications.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37156&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37156">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-37156.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Dakin&#x000a0;solution, also called Dakin fluid or Carrel-Dakin fluid, is a dilute sodium hypochlorite (NaClO) solution commonly known as bleach.<xref ref-type="bibr" rid="article-37156.r1">[1]</xref> The sodium peroxide (NaO) and hydrochloric acid (HCl) mixture produces sodium hypochlorite. The main active agent in Dakin solution is created when the chlorine reacts with water in the environment to form hypochlorous acid (HClO). This hypochlorous acid produces a potent antibacterial effect in tissues. Neutrophils of the human immune system produce small amounts of hypochlorous acid inside phagosomes, which are used to digest bacteria and viruses. Unlike stronger germicidal solutions that contain&#x000a0;carbolic acid or iodine,&#x000a0;Dakin does not damage living&#x000a0;cells or lose potency in the presence of blood serum.&#x000a0;It has a solvent action on dead cells that hastens the separation of dead tissue from living tissue.&#x000a0;Sodium hypochlorite solution must be buffered before use. The most commonly used substances are boric acid and sodium bicarbonate.</p>
        <p>English chemist Henry Dakin and French surgeon Alexis Carrel developed a Dakin&#x000a0;solution to clean and rinse wounds. It was originally formulated as a battlefield wound antiseptic during World War I.<xref ref-type="bibr" rid="article-37156.r2">[2]</xref> They devised the Carrel-Dakin treatment to irrigate wounds after surgical debridements were performed to preserve and save limbs. As a result of their work, Dakin solution has saved many lives (and limbs) since its creation.<xref ref-type="bibr" rid="article-37156.r3">[3]</xref>&#x000a0;The low cost and effectiveness of Dakin&#x000a0;solution make&#x000a0;this bactericidal antiseptic very popular in the healthcare field. It treats or prevents infections from cuts, abrasions, lacerations, skin ulcers, stage I to IV pressure ulcers, first- and second-degree burns, and even during surgery.<xref ref-type="bibr" rid="article-37156.r2">[2]</xref> Its efficacy has been compared to negative pressure wound therapy for treating diabetic foot ulcer infections.<xref ref-type="bibr" rid="article-37156.r4">[4]</xref> This is why Dakin&#x000a0;solution (usually in a diluted form) continues to be&#x000a0;used&#x000a0;in practice today.<xref ref-type="bibr" rid="article-37156.r5">[5]</xref></p>
      </sec>
      <sec id="article-37156.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Dakin solution is a strong topical antiseptic widely used to clean infected wounds, ulcers, and burns.<xref ref-type="bibr" rid="article-37156.r6">[6]</xref> Full-strength Dakin&#x000a0;solution is usually diluted in water, depending on its intended use. A 0.5% solution of hypochlorite (containing approximately 5000 ppm free chlorine) is used for disinfecting areas contaminated with bodily fluids, including large blood spills (after the area has been cleaned with a detergent). Dilute Dakin&#x000a0;solution (0.05% to 0.025%) can be used&#x000a0;to&#x000a0;irrigate, cleanse, or as a component in wet-to-dry dressings to treat or prevent skin and soft tissue infections.<xref ref-type="bibr" rid="article-37156.r5">[5]</xref>&#x000a0;</p>
        <p>The mechanism of action of Dakin&#x000a0;solution is mostly unknown, but it acts as a germicidal, bacteriostatic topical agent that can dissolve necrotic tissue debris. Dakin solution is effective against a broad spectrum of aerobic and anaerobic bacteria, viruses, fungi, and spores. It has bactericidal activity against a variety of organisms, including <italic toggle="yes">Enterococcus</italic>, <italic toggle="yes">Streptococcus mitis</italic>, <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Staphylococcus epidermidis</italic>, <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Klebsiella pneumonia</italic>, <italic toggle="yes">Enterobacter cloacae</italic>, <italic toggle="yes">Serratia marcescens</italic>, <italic toggle="yes">Proteus mirabilis,</italic> and <italic toggle="yes">Pseudomonas aeruginosa</italic>. It has even been effective against organisms highly resistant to antibiotics, such as methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;and vancomycin-resistant <italic toggle="yes">Enterococcus</italic>.<xref ref-type="bibr" rid="article-37156.r7">[7]</xref><xref ref-type="bibr" rid="article-37156.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-37156.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Due to its properties as an acid-based compound, Dakin&#x000a0;solution can be corrosive to healthy tissue, especially at higher concentrations. An oil-based ointment such as petroleum jelly can be applied to surrounding healthy tissue to reduce skin irritation and prevent the debridement of viable tissue. Dakin&#x000a0;solution also loses its antiseptic properties rapidly after application due to the instability of the compound. Therefore, gauze sponges soaked with Dakin used to pack necrotic wounds must be frequently changed. It is usually applied twice daily to lightly to moderately exudative wounds and twice daily for highly exudative or contaminated wounds.<xref ref-type="bibr" rid="article-37156.r5">[5]</xref></p>
      </sec>
      <sec id="article-37156.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Dakin solution's most common side effects include redness, swelling, and skin irritation. The main concerns for using Dakin&#x000a0;fluid are allergic reactions, skin hypersensitivity, and impaired wound healing, which can occur when using high concentrations of Dakin&#x000a0;due to fibroblast toxicity.<xref ref-type="bibr" rid="article-37156.r8">[8]</xref>&#x000a0;Dakin solution is often used in pregnancy and lactation because there is limited systemic absorption. However, it is classified as a category C agent by the FDA. Dakin has shown adverse fetal effects in animal reproduction studies,&#x000a0;but there have been no adequate, well-controlled human studies. For this reason, the potential benefits of the solution in pregnant women warrant its use, notwithstanding the possible risk to the fetus.</p>
        <p>The labeling on Dakin&#x000a0;solution may&#x000a0;cause some confusion for healthcare providers regarding its strength.&#x000a0;The labels list strengths as full strength at 0.5%, half strength at 0.25%, and quarter strength at 0.125%. This terminology can confuse healthcare providers, considering that half and quarter strengths correspond to 0.5% and 0.25%, respectively. Of note, most hospitals use a modified Dakin&#x000a0;solution of 0.025% for wound care, and studies have suggested that concentrations of Dakin&#x000a0;solution greater than 0.025% may potentially be harmful to wound healing.<xref ref-type="bibr" rid="article-37156.r9">[9]</xref></p>
      </sec>
      <sec id="article-37156.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to using Dakin&#x000a0;solution include hypersensitivity to sodium hypochlorite, chlorine compounds, or any formulation component. Concomitant use of&#x000a0;taurolidine (an antimicrobial used to prevent catheter infections) may enhance sodium hypochlorite's adverse/toxic effect. Specifically, concomitant use of taurolidine and sodium hypochlorite may increase the risk of metabolic acidosis.<xref ref-type="bibr" rid="article-37156.r1">[1]</xref></p>
      </sec>
      <sec id="article-37156.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Wounds only need to be monitored to ensure proper healing. If there appears to be an adverse reaction&#x000a0;when applying Dakin&#x000a0;solution, it should be discontinued immediately.</p>
      </sec>
      <sec id="article-37156.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Ingesting diluted sodium hypochlorite generally causes only mild stomach irritation;&#x000a0;however, swallowing larger amounts can cause more serious symptoms, including chest pain, delirium, hypotension, burns to the gastrointestinal&#x000a0;tract, shock, bradycardia, nausea, and vomiting.<xref ref-type="bibr" rid="article-37156.r10">[10]</xref> The concentration of sodium hypochlorite in industrial-strength bleach is high and may cause severe injury.<xref ref-type="bibr" rid="article-37156.r8">[8]</xref>&#x000a0;Never mixing ammonia with sodium hypochlorite (bleach or bleach-containing products) is important. This mixture can produce toxic chlorine gas that can cause choking and serious breathing problems. HCl is formed when chlorine gas contacts moist tissues like&#x000a0;the eyes or lungs.&#x000a0;HCl is a digestive juice that damages tissue;&#x000a0;it can damage the airways, cause asphyxiation, and result in death. It is important to note that activated charcoal does not effectively treat (adsorb) sodium hypochlorite. Treatment depends on the severity of the toxicity with medical management for mild-moderate cases of toxicity to surgery if there are perforations noted along the gastrointestinal&#x000a0;tract.</p>
      </sec>
      <sec id="article-37156.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Dakin solution bactericidal antiseptic is very popular. Clinicians (MDs, DOs, DPMs, NPs, and PAs), surgeons, nurses, and pharmacists should&#x000a0;know its use, appropriate concentrations, and potential adverse effects. It treats or prevents infections from cuts, abrasions, lacerations, skin ulcers, stage I to IV pressure ulcers, first- and second-degree burns, and even during surgery. An interprofessional team approach to its use provides the best patient outcomes.<xref ref-type="bibr" rid="article-37156.r11">[11]</xref></p>
      </sec>
      <sec id="article-37156.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37156&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37156">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/37156/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=37156">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-37156.s11">
        <title>References</title>
        <ref id="article-37156.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Dakin's solution: past, present, and future.</article-title>
            <source>Adv Skin Wound Care</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>9</issue>
            <fpage>410</fpage>
            <page-range>410-4</page-range>
            <pub-id pub-id-type="pmid">23958873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Georgiadis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Donat</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Okereke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shoja</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Dakin's Solution: "One of the most important and far-reaching contributions to the armamentarium of the surgeons".</article-title>
            <source>Burns</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>1509</fpage>
            <page-range>1509-1517</page-range>
            <pub-id pub-id-type="pmid">30591251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sabbatani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fiorino</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The treatment of wounds during World War I.</article-title>
            <source>Infez Med</source>
            <year>2017</year>
            <month>Jun</month>
            <day>01</day>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-192</page-range>
            <pub-id pub-id-type="pmid">28603241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duarte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Formiga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Dakin's solution in the treatment of severe diabetic foot infections.</article-title>
            <source>Int Wound J</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>277</fpage>
            <page-range>277-284</page-range>
            <pub-id pub-id-type="pmid">31721437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCullough</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Dakin's solution: historical perspective and current practice.</article-title>
            <source>Ann Plast Surg</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>73</volume>
            <issue>3</issue>
            <fpage>254</fpage>
            <page-range>254-6</page-range>
            <pub-id pub-id-type="pmid">25121415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duarte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cabete</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Formiga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Dakin's solution: is there a place for it in the 21st century?</article-title>
            <source>Int Wound J</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>918</fpage>
            <page-range>918-920</page-range>
            <pub-id pub-id-type="pmid">28198104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Estes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McLaren</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spangehl</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Chlorhexidine Antiseptic Irrigation Eradicates Staphylococcus epidermidis From Biofilm: An In Vitro Study.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>476</volume>
            <issue>3</issue>
            <fpage>648</fpage>
            <page-range>648-653</page-range>
            <pub-id pub-id-type="pmid">29443852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aubut</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pommel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Verhille</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Orsi&#x000e8;re</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>About</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Camps</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Biological properties of a neutralized 2.5% sodium hypochlorite solution.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>e120</fpage>
            <page-range>e120-5</page-range>
            <pub-id pub-id-type="pmid">19969489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cardile</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Hurtgen</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Wenke</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Akers</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Dakin solution alters macrophage viability and function.</article-title>
            <source>J Surg Res</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>192</volume>
            <issue>2</issue>
            <fpage>692</fpage>
            <page-range>692-9</page-range>
            <pub-id pub-id-type="pmid">25130774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slaughter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Grieve</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Schep</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>The clinical toxicology of sodium hypochlorite.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2019</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>303</fpage>
            <page-range>303-311</page-range>
            <pub-id pub-id-type="pmid">30689457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37156.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Bohn</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Glat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kavros</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kirsner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tettelbach</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Expert Recommendations for the Use of Hypochlorous Solution: Science and Clinical Application.</article-title>
            <source>Ostomy Wound Manage</source>
            <year>2015</year>
            <month>May</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>S2</fpage>
            <page-range>S2-S19</page-range>
            <pub-id pub-id-type="pmid">28692424</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
